ArticleInternational journal of molecular sciences2025
Shorter Telomere Length in Individuals with Neurocognitive Disorder and
Paola Mejía-Ortiz, Alma Delia Genis-Mendoza, Ramon Ramírez Villanueva, Susana López Ramírez, Rafael Guzmán Sánchez, Thalia Fernández, Jorge Sigg-Alonso, Humberto Nicolini-Sánchez
Abstract read
In one paragraphArticle in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Paola Mejía-OrtizPosgrado en Ciencias (Neurobiología), Unidad de Enseñanza Instituto de Neurobiología, Universidad Nacional Autónoma de México, Campus Juriquilla 3001, Querétaro C.P. 76230, Mexico.
Alma Delia Genis-MendozaLaboratorio de Genómica de las Enfermedades Psiquiátricas y Neurodegenerativas, Instituto Nacional de Medicina Genómica, Secretaría de Salud, Ciudad de México C.P. 14610, Mexico.
Ramon Ramírez VillanuevaServicio de Geriatría y Gerontología, ISSSTE Clínica de Medicina Familiar Dr. Ignacio Chávez, Oriental 10, Coapa, Coyoacán, Ciudad de México C.P. 04800, Mexico.
Susana López RamírezServicio de Geriatría y Gerontología, ISSSTE Clínica de Medicina Familiar Dr. Ignacio Chávez, Oriental 10, Coapa, Coyoacán, Ciudad de México C.P. 04800, Mexico.
Rafael Guzmán SánchezServicio de Geriatría y Gerontología, ISSSTE Clínica de Medicina Familiar Dr. Ignacio Chávez, Oriental 10, Coapa, Coyoacán, Ciudad de México C.P. 04800, Mexico.
Thalia FernándezLaboratorio de Psicofisiología, Departamento de Neurobiología Conductual y Cognitiva, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Campus Juriquilla 3001, Querétaro C.P. 76230, Mexico.ORCID 0000-0002-2842-7773 Jorge Sigg-AlonsoLaboratorio de Psicofisiología, Departamento de Neurobiología Conductual y Cognitiva, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Campus Juriquilla 3001, Querétaro C.P. 76230, Mexico.
Humberto Nicolini-SánchezHospital Psiquiátrico Infantil Dr. Juan N. Navarro, Servicios de Atención Psiquiátrica, Secretaria de Salud, Periferico sur 4809, Tlalpan CDMX, Ciudad de México C.P. 14610, Mexico.ORCID 0000-0003-2494-0067 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Neurocognitive disorders (NCD) are neurodegenerative diseases characterized by decline or loss of cognitive functions. Aging and the
Indexed as
Apolipoprotein E4Cognitive DysfunctionNeurocognitive DisordersTelomereTelomere ShorteningAgedAged, 80 and overFemaleGenotypeHumansMaleMiddle AgedRisk FactorsApolipoprotein E4APOEcognitive impairmentcognitive reserveneurocognitive disordertelomere length
Identifiers
PMID40429722
PMCPMC12111326
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390